Enclomiphene direct vs clomiphene: what's the real difference

Last updated 2026-07-27

What is the actual difference between enclomiphene and clomiphene?

Clomiphene citrate, the drug sold for decades under the brand name Clomid, isn't one molecule. It's a mixture of two geometric isomers, enclomiphene (the trans isomer) and zuclomiphene (the cis isomer), combined roughly 62:38 by weight in the commercial product ^[1]. Enclomiphene is the isomer that acts as an estrogen receptor antagonist at the hypothalamus, which is the mechanism that drives up LH, FSH, and downstream testosterone. Zuclomiphene behaves more like a weak estrogen agonist and clears the body far more slowly, with a half-life measured in weeks rather than days ^[2]. So enclomiphene isn't a new drug chemically speaking. It's half of a drug that's been on the market since 1967. The pitch behind isolating it was straightforward: keep the isomer that does the job you want (raising LH and testosterone) and drop the one that lingers and may contribute to mood and visual side effects reported with clomiphene ^[3]. If you want dosing specifics once you understand the pharmacology, see Enclomiphene Direct dosage and the Enclomiphene Direct dosage calculator.

How does each drug actually raise testosterone?

Both compounds work the same basic way: they block estrogen receptors in the hypothalamus. Your hypothalamus monitors circulating estrogen (converted from testosterone) as part of a negative feedback loop. Block that signal, and the hypothalamus reads it as "estrogen is low," so it pumps out more GnRH, which drives the pituitary to release more LH and FSH, which tells the testes to make more testosterone and support sperm production. This is the opposite mechanism from injectable testosterone (TRT). Exogenous testosterone raises blood levels directly, but it also tells the hypothalamus "we have plenty," which shuts down GnRH, LH, and FSH. That's why standard TRT commonly suppresses sperm production and can shrink testicular volume over months of use ^[4]. Enclomiphene and clomiphene, because they raise testosterone by stimulating the man's own axis rather than replacing the hormone, don't carry that same direct suppressive signal, which is the whole reason men interested in fertility look at them instead of TRT. That said, "doesn't suppress the axis" is not the same claim as "preserves fertility" in the sense of guaranteed sperm counts or pregnancy outcomes. It's a mechanistic difference, and the clinical evidence for hard fertility endpoints in men is thinner than the marketing around this class of drugs suggests. More on that below.

Does enclomiphene preserve fertility better than clomiphene, or is it the same?

Since enclomiphene is the isomer responsible for the LH/FSH stimulation, in theory it should preserve or raise sperm-supportive hormone signaling just as well as clomiphene, without the accumulating zuclomiphene along for the ride. In practice, there is no large head-to-head randomized trial comparing pregnancy rates or live sperm counts between pure enclomiphene and full clomiphene citrate in subfertile men. What does exist: a small trial (Kim et al., published in the Journal of Sexual Medicine, 2020, n=12 men) compared enclomiphene to testosterone gel and found enclomiphene maintained sperm concentration while testosterone gel suppressed it significantly over 3 months ^[5]. A separate earlier phase 2 program (the Androxal development studies, sponsored by Repros Therapeutics) reported that enclomiphene raised serum testosterone into the normal range while maintaining LH, FSH, and sperm parameters better than exogenous testosterone in secondary hypogonadism, but these were company-sponsored studies that never reached FDA approval ^[6]. So the honest answer is: mechanistically enclomiphene should behave like the "active half" of clomiphene with a cleaner side-effect profile, and the limited data available is consistent with that. But nobody has run the definitive trial proving enclomiphene beats clomiphene on pregnancy rate or sperm count in men trying to conceive. If a clinic promises you a specific fertility outcome from either drug, that promise is ahead of the evidence.

Is enclomiphene FDA-approved? Is clomiphene?

Clomiphene citrate is FDA-approved, but only for female infertility (ovulation induction) under the brand name Clomid, originally approved in 1967 ^[7]. It has never been FDA-approved for treating low testosterone in men. Any use in men is off-label, though off-label prescribing is legal and common. Enclomiphene has never been FDA-approved for any indication. Repros Therapeutics ran it through clinical trials under the name Androxal for male hypogonadotropic hypogonadism (low testosterone caused by reduced pituitary signaling), and the program included Phase 3 studies, but Repros withdrew the program and it never received FDA approval or a New Drug Application clearance ^[8]. The company folded and the drug was never brought to market as a licensed product. This matters practically because it means enclomiphene sold today isn't a manufactured, FDA-approved pharmaceutical. It's produced by compounding pharmacies under a doctor's prescription, using the same legal framework that lets pharmacies compound other medications for individual patients (regulated under Section 503A of the Federal Food, Drug, and Cosmetic Act for traditional compounders, or 503B for outsourcing facilities) ^[9]. Compounded drugs don't go through the FDA's efficacy and manufacturing-consistency review that approved drugs do. That doesn't mean they're unsafe or fake, but it does mean the quality assurance burden shifts to which pharmacy is doing the compounding and how the prescriber is monitoring you.

Enclomiphene vs clomiphene: side by side

Why do men choose enclomiphene over TRT at all?

The core appeal isn't enclomiphene vs. clomiphene, it's SERMs vs. exogenous testosterone. Men who want higher testosterone but also want to keep sperm production intact, or avoid testicular shrinkage, gravitate toward enclomiphene (or clomiphene) because the mechanism stimulates the body's own axis rather than replacing the hormone directly. TRT's effect on fertility is well documented: studies consistently show that exogenous testosterone suppresses spermatogenesis in the large majority of men within months, and it's been investigated as a male contraceptive precisely because of this effect ^[4]. Recovery of fertility after stopping TRT is common but not universal or instant, and can take many months. Enclomiphene avoids this specific mechanism of suppression because it doesn't add testosterone from outside, it triggers the pituitary to ask the testes to make more. That's a real and clinically sensible distinction. It is not, however, proof that every man on enclomiphene keeps normal fertility, and men with primary testicular failure (as opposed to a hypothalamic/pituitary signaling issue) generally don't respond to enclomiphene or clomiphene at all, since the problem isn't insufficient LH/FSH signal, it's testes that can't respond to it.

What are the side effects of enclomiphene compared to clomiphene?

Reported side effects overlap heavily because the mechanism overlaps. Both can cause headache, mood changes, hot flashes, and in some men, visual disturbances (blurred vision, seeing halos), which is a known class effect of clomiphene and the reason the drug carries visual-disturbance warnings on its label ^[10]. The theoretical argument for enclomiphene causing fewer estrogenic or mood-related side effects rests on it clearing the zuclomiphene isomer, which has weak estrogenic agonist activity and hangs around in the body far longer. Small studies support the idea that enclomiphene produces smaller estradiol swings than full clomiphene in some men ^[3][5], but the trials are small (low double digits to low hundreds of participants), short in duration, and not powered to detect rare side effects. Practically: if you've had a bad experience with clomiphene (bad mood, visual symptoms, or slow recovery of feeling normal after stopping), it's reasonable to think enclomiphene might be gentler. But treat that as a plausible hypothesis with some supporting mechanistic and pilot data, not an established clinical fact backed by large trials.

How is enclomiphene dosed compared to clomiphene?

Because enclomiphene is the concentrated active isomer, typical protocols use lower absolute doses than whole clomiphene citrate. Clomiphene for off-label male use is commonly dosed at 25 to 50 mg every other day or daily. Compounded enclomiphene protocols often run in the 12.5 to 25 mg per day range, though there's no FDA-approved dosing standard since neither approved indication covers this population, and protocols vary meaningfully between prescribers. Because you're working with a compounded product without a standardized commercial dose, the practical starting point is your prescriber's titration based on baseline labs (total and free testosterone, LH, FSH, estradiol) and a follow-up panel 4 to 6 weeks in. For the mechanics of how a typical protocol is structured, see Enclomiphene Direct dosage and run your own numbers with the Enclomiphene Direct dosage calculator. If your prescription arrives as a powder requiring reconstitution, how to reconstitute Enclomiphene Direct walks through that process, and if it's injectable rather than oral, check Enclomiphene Direct how to inject and Enclomiphene Direct injection sites.

Can you just take clomiphene instead of paying more for enclomiphene?

Yes, mechanically. Clomiphene is generic, cheap, and available at any retail pharmacy with a prescription, often for $20 to $40 a month out of pocket. Enclomiphene, being compounded, usually costs more, often somewhere in the range of $75 to $150+ per month depending on the pharmacy and dose, though prices vary a lot and aren't standardized the way generic drug pricing is. Whether the price premium is worth it depends on how you respond to the zuclomiphene component. Some men do fine on generic clomiphene and see no reason to switch. Others report the mood or visual side effects hard enough that isolating out the enclomiphene fraction feels worth the extra cost. There's no lab test that tells you in advance which group you're in; it's trial and observation, ideally under a prescriber who's tracking your labs and symptoms over a few months either way. If cost is the deciding factor and you haven't tried clomiphene first, there's a reasonable argument for starting with the cheaper, FDA-approved-for-something molecule and switching only if side effects show up. That's a conversation to have with your prescriber, not a decision to make from a price chart alone.

Where do you actually get enclomiphene, and does that matter?

Since no manufacturer sells FDA-approved enclomiphene, every legal source is a compounding pharmacy filling an individual prescription. That means the two things that actually matter are (1) whether a licensed prescriber is evaluating your labs and writing the prescription, and (2) which pharmacy is doing the compounding, since compounded drug quality isn't verified by FDA the way manufactured generics are. Enclomiphene Direct's model is built around the provider-reviewed part of that chain: a clinician reviews your labs and history before anything ships, and the prescription is filled by a named compounding pharmacy partner rather than an unnamed or offshore source. That doesn't change the regulatory status of the drug itself, compounded is compounded, but it does mean there's a licensed prescriber and a specific accountable pharmacy behind what arrives at your door, instead of a gray-market import with no clinical oversight at all. Whatever route you use, ask directly: who is the prescribing clinician, and which pharmacy is compounding this? If a seller can't answer both questions specifically, that's a real red flag, not a minor detail.

What should you ask your doctor before choosing one over the other?

Bring baseline labs to the conversation: total testosterone (ideally two morning draws), free testosterone, LH, FSH, and estradiol. These numbers determine whether you even have a hypothalamic/pituitary-driven low testosterone that a SERM can treat, versus primary testicular failure, where enclomiphene and clomiphene generally don't work. Ask specifically about fertility timeline if that's your priority: are you trying to conceive now, in the next year, or just want to avoid closing the door? That changes the calculus around TRT, clomiphene, and enclomiphene meaningfully. Ask what monitoring looks like: follow-up labs at 4 to 6 weeks, and again at 3 months, are reasonable asks regardless of which drug you choose. And ask plainly whether your prescriber has experience with both drugs in men, since off-label use of either means less standardized protocol guidance than an FDA-approved indication would provide.

Frequently asked questions

Is enclomiphene stronger than clomiphene?

Not exactly "stronger." Enclomiphene is the active isomer within clomiphene that does the testosterone-raising work. Milligram for milligram of the active component, effects on LH/FSH/testosterone should be similar; enclomiphene protocols just use lower absolute doses because they skip the inactive zuclomiphene bulk.

Is enclomiphene the same as Clomid?

No. Clomid (clomiphene citrate) is a mixture of two isomers, enclomiphene and zuclomiphene, combined at roughly 62:38 ^[1]. Enclomiphene is one isolated component of Clomid, not a separate drug from a different family, and not identical to the full clomiphene molecule you'd get filling a Clomid prescription.

Does enclomiphene preserve fertility better than clomiphene?

Mechanistically it should, since it's the LH/FSH-stimulating isomer without the long-lingering zuclomiphene. But there's no large trial directly comparing pregnancy rates or sperm counts between the two in men. Small studies support the theory; nobody has proven it head-to-head at scale ^[5][6].

Is enclomiphene FDA-approved?

No. Enclomiphene (branded Androxal in development) went through clinical trials but the sponsor, Repros Therapeutics, never gained FDA approval and the program was discontinued ^[8]. Everything sold today is compounded by a pharmacy under an individual prescription, not manufactured as an approved drug.

Is clomiphene FDA-approved for men?

Clomiphene citrate is FDA-approved only for female ovulation induction, originally approved in 1967 under the name Clomid ^[7]. Its use in men for low testosterone is entirely off-label, which is legal but means there's no FDA-reviewed dosing standard for that use.

Does enclomiphene shrink your testicles like TRT can?

No, and that's the main reason men choose it over TRT. Enclomiphene stimulates the pituitary to increase LH and FSH, which maintains testicular signaling, unlike exogenous testosterone, which suppresses that signal and can reduce testicular volume over time ^[4].

How much does enclomiphene cost compared to clomiphene?

Generic clomiphene often runs $20 to $40 a month at a retail pharmacy. Compounded enclomiphene typically costs more, often in the $75 to $150+ per month range depending on pharmacy and dose, since pricing isn't standardized for compounded products the way it is for generics.

Can enclomiphene help me get my wife pregnant?

It may help if your low testosterone stems from hypothalamic or pituitary signaling problems, by raising LH, FSH, and sperm-supportive hormone levels. It won't help if the cause is primary testicular failure. No study has established a guaranteed pregnancy rate for enclomiphene use, so treat it as a plausible tool, not a guaranteed fertility fix.

What are the main side effects of enclomiphene vs clomiphene?

Both share headache, mood changes, hot flashes, and occasional visual disturbances, a known clomiphene class effect ^[10]. Some pilot data suggests enclomiphene causes smaller estradiol swings and possibly fewer estrogen-related side effects because it lacks the zuclomiphene component, but this isn't confirmed in large trials.

Who should not take enclomiphene or clomiphene?

Men with primary testicular failure (testes that can't respond to LH/FSH signal) generally won't benefit, since the problem isn't insufficient pituitary signaling. Anyone with a history of estrogen-sensitive conditions, certain liver conditions, or uncontrolled visual/eye problems should discuss those specifically with a prescriber before starting either drug.

Where can I legally get enclomiphene?

Only through a prescription filled by a licensed compounding pharmacy, since no FDA-approved manufactured version exists. Look for a provider who reviews your labs before prescribing and a named, accountable compounding pharmacy partner, rather than an unnamed overseas or gray-market source.

How long does it take for enclomiphene to raise testosterone?

Small studies and typical clinical protocols show measurable testosterone increases within 2 to 4 weeks, with labs usually rechecked at the 4 to 6 week mark to guide dose adjustments. Full stabilization of the hormonal picture, including estradiol and LH/FSH balance, often takes closer to 3 months.

Sources

1. DrugBank, Clomiphene entry (isomer composition): Clomiphene citrate is a mixture of enclomiphene and zuclomiphene isomers in roughly 62:38 ratio
2. PubMed, Mikkelson et al., pharmacokinetics of clomiphene isomers: Zuclomiphene has a much longer half-life and persists in circulation longer than enclomiphene
3. PubMed, Kim ED et al., enclomiphene review: Enclomiphene is proposed to reduce estrogenic side effects relative to full clomiphene by eliminating zuclomiphene exposure
4. Endocrine Society, Testosterone Therapy in Men with Hypogonadism Clinical Practice Guideline: Exogenous testosterone therapy suppresses spermatogenesis and gonadotropin secretion in men
5. Journal of Sexual Medicine, Kim et al. 2020, enclomiphene vs testosterone gel: Enclomiphene maintained sperm concentration while testosterone gel suppressed it over a 3-month comparison
6. Repros Therapeutics, Androxal Phase 3 program disclosures (via SEC/clinicaltrials.gov record): Androxal (enclomiphene) Phase 3 trials studied testosterone and gonadotropin response in men with secondary hypogonadism
7. FDA, Clomid (clomiphene citrate) approval history via Drugs@FDA: Clomiphene citrate (Clomid) was approved by FDA in 1967 for ovulation induction
8. FDA, Drugs@FDA database search (Androxal/enclomiphene, no approved application): Enclomiphene (Androxal) has no FDA-approved New Drug Application on record
9. FDA, Human Drug Compounding, Section 503A and 503B overview: Compounded drugs are produced under Sections 503A/503B of the FD&C Act and are not FDA-approved products
10. FDA label, Clomid (clomiphene citrate) prescribing information: Clomiphene citrate labeling includes warnings for visual disturbances as a known adverse effect